Related Experiment Videos

MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells

Nailin Huo1, Yasushi Ichikawa, Masako Kamiyama

  • 1Department of Surgery-2, Yokohama City University School of Medicine, 3-9 Fukuura kanazawa-ku, Yokohama 236-0004, Japan.

Cancer Letters
|January 26, 2002
PubMed

Insights

Matrix metalloproteinase-7 (MMP-7) directly promotes angiogenesis by accelerating endothelial cell proliferation. This finding suggests MMP-7 is a potential therapeutic target for cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Matrix metalloproteinases (MMPs) are crucial in angiogenesis.
  • MMP-7 (matrilysin) is linked to cancer metastasis, but its role in angiogenesis is unclear.

Purpose of the Study:

  • To investigate the effect of MMP-7 on the proliferation of human umbilical vein endothelial cells (HUVECs) in vitro.
  • To determine if MMP-7 directly influences angiogenic processes.

Main Methods:

  • Recombinant MMP-7 (rMMP-7) was used to treat HUVECs cultured on different collagen types.
  • Cell proliferation was measured.
  • Secretion of MMP-1, MMP-2, and vascular endothelial growth factor (VEGF) was analyzed.

Main Results:

  • rMMP-7 dose-dependently accelerated HUVEC proliferation on type I and type IV collagen.
  • MMP-7 upregulated the secretion of MMP-1 and MMP-2.
  • MMP-7 did not stimulate VEGF secretion.

Conclusions:

  • MMP-7 directly induces angiogenesis by promoting endothelial cell proliferation.
  • MMP-7 represents a promising therapeutic target for anti-cancer strategies.

Related Concept Videos